Biophen Arixtra Control Plasma (2017-09-01)

Biophen Arixtra Control Plasma Recall Biophen Arixtra Control Plasma, a medical device used for testing blood clotting, is being recalled across Canada. The recall was issued on September 1, 2017, and is classified as Class I, indicating a serious health hazard. This product was distributed nationwide in Canada.

Reason

Medical devices

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DEVICES

Recall date

2017-09-26

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/e1d96e0e-49d3-4182-8d4c-b17734d3e7e9